SHE/301301 (SHE/301301)

Shenzhen Stock Exchange: SHE/301301 · CNY

CN¥7.21

+0.00 (0.0%)· Recorded snapshot

Market cap	16.1B
Revenue (ttm)	4.1B
Net income (ttm)	490M
EPS (ttm)	CN¥0.22
Shares out	2.2B
P/E (trailing)	32.7x
P/E (forward)	17.6x
Dividend	CN¥0.17 (2.40%)
Volume	7,494,500
Beta	0.02

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.1B
Net income (ttm): 490M
EPS (ttm): CN¥0.22
P/E (trailing): 32.7x
P/E (forward): 17.6x
Market cap: 16.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E17.6

P25 n/aP50 n/aP75 n/a

Trailing P/E32.7

P25 n/aP50 n/aP75 n/a

ROE6.1

P25 n/aP50 n/aP75 n/a

ROIC6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SHE/301301 indicators

Market & fundamental data

Available fields

229

Groups with data

Currency

CNY

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CNY
Country	China
Country code	CN
Earnings date	2026-10-23
Employees	3,126
Employees change	-58
Employees growth	-1.82%
Enterprise value	CNY 16.5B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	2010
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CNE100005WX0
Last earnings date	2026-10-23
Last refreshed	2026-10-28
Market cap	CNY 16.1B
Next earnings date	2027-03-30
Price	CNY 7.21
Price currency	CNY
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	she/301301
Website	https://www.klcnsw.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	25.76x
Average P/E ratio (5Y)	29.03x
Earnings yield	3.05%
EV/Earnings	33.71x
EV/EBIT	26.7x
EV/EBITDA	13.46x
EV/FCF	23.14x
EV/Sales	4.07x
FCF / EV yield	4.32%
FCF yield	4.43%
Forward P/E	17.59x
Graham number	4.2238
Graham upside	-41.42%
Industry forward P/E	36.91x
Lynch fair value	CNY 5.50
Lynch upside	-23.65%
P/B ratio	2x
P/E ratio	32.75x
P/FCF ratio	22.55x
P/OCF ratio	20.09x
P/S ratio	3.96x
Price / tangible book value	2.06x
Price/EBITDA ratio	13.31x
Sector forward P/E	20.21x
Sector P/E	37.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	15.23%
EBITDA margin	29.77%
Effective tax rate	18.18%
FCF margin	17.57%
Gross margin	22.11%
Operating margin	15.23%
Pretax margin	14.58%
Profit margin	12.06%
Profit per employee	CNY 156,765
Revenue per employee	CNY 1.3M
ROA	3.74%
ROA (5Y)	6.06%
ROCE	7.18%
ROE	6.05%
ROE (5Y)	10.5%
ROIC	6.02%
ROIC (5Y)	10.15%
Tax / revenue	2.65%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-47.3%
EPS growth (Q)	-61.08%
EPS growth (QoQ)	-60.77%
EPS growth 3Y	-13.03%
FCF growth	-51.08%
FCF growth (Q)	-82.63%
FCF growth (QoQ)	-95.78%
FCF growth 3Y	-25.01%
Gross profit growth	-44.17%
Gross profit growth (Q)	-49.14%
Gross profit growth 3Y	-8.5%
Gross profit growth 5Y	11.22%
Net income growth	-47.63%
Net income growth (Q)	-64.91%
Net income growth (QoQ)	-67.07%
Net income growth 3Y	-12.01%
Net income growth 5Y	39.92%
OCF growth	-46.1%
OCF growth (Q)	-73.33%
OCF growth (QoQ)	-91.93%
OCF growth 3Y	-24.98%
Operating income growth	-48.57%
Operating income growth (Q)	-55.39%
Operating income growth 3Y	-14.62%
Operating income growth 5Y	15.31%
Revenue growth	-14.25%
Revenue growth (Q)	-27.8%
Revenue growth (QoQ)	-21.74%
Revenue growth 3Y	-3.08%
Revenue growth 5Y	5.27%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CNY -87.5M
Depreciation and amortization	CNY 591M
EBIT	CNY 618.7M
EBITDA	CNY 1.2B
EPS	CNY 0.22
FCF per share	CNY 0.32
Financing cash flow	CNY -571M
Free cash flow	CNY 713.8M
Gross profit	CNY 898.2M
Income taxes	CNY 107.7M
Investing cash flow	CNY -240.5M
Net borrowing	CNY -141.8M
Net cash flow	CNY -15.4M
Net income	CNY 490M
Operating income	CNY 618.7M
Revenue	CNY 4.1B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	6.98
Book value per share	CNY 3.60
Debt / EBITDA	1.05
Debt / equity	0.16
Debt / FCF	1.8
Goodwill	CNY 1.4M
Interest coverage	20.49
Long-term assets	CNY 6B
Long-term liabilities	CNY 558.1M
Net cash (debt)	CNY -402.4M
Net cash / market cap	-2.5%
Net debt / EBITDA	0.33
Net debt / equity	0.05
Net debt / FCF	0.56
Piotroski F-Score	5
Property, plant and equipment	CNY 5.4B
Shareholders' equity	CNY 8.1B
Tangible book value	CNY 7.8B
Tangible book value per share	CNY 3.50
Total assets	CNY 10.4B
Total cash	CNY 885.4M
Total debt	CNY 1.3B
Total liabilities	CNY 2.3B
WACC	4.19%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.39
Current assets	CNY 4.3B
Current liabilities	CNY 1.7B
Current ratio	2.48
Inventory turnover	2.3
Net working capital	CNY 2.5B
Quick ratio	1.33
Working capital	CNY 2.6B
Working capital turnover	1.69

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.64%
Dividend growth	-35.84%
Dividend growth years	2
Dividend payment date	2026-04-29
Dividend payment years	4
Dividend payout frequency	Annual
Dividend per share	CNY 0.17
Dividend yield	2.4%
Ex-dividend date	2026-04-29
FCF payout ratio	46.53%
Last dividend	CNY 0.17
Payout ratio	82.25%
Shareholder yield	3.04%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CNY 9.02
1D price change	0%
1M price change	-10.1%
1M total return	-10.1%
1W price change	-9.54%
1W total return	-9.54%
1Y price change	-35.22%
1Y return CAGR	-34.07%
1Y total return	-34.05%
20-day SMA	CNY 7.92
200-day SMA	CNY 9.52
3M price change	-13.86%
3M total return	-13.86%
3Y price change	-17.79%
3Y return CAGR	-4.62%
3Y total return	-13.24%
50-day SMA	CNY 8.33
50-day SMA vs 200-day SMA	50under200
52-week high	CNY 12.90
52-week high date	2026-01-13
52-week low	CNY 7.18
52-week low date	2026-10-23
6M price change	-27.32%
6M total return	-26.01%
All-time high	CNY 18.33
All-time high date	2024-05-08
All-time low	CNY 6.94
All-time low date	2024-02-05
Average true range (ATR)	CNY 0.25
Average volume	11.6M
Beta (1Y)	0.28
Beta (2Y)	0.49
Beta (5Y)	0.02
Change from 52-week high	-44.11%
Change from 52-week low	0.42%
Change from all-time high	-60.67%
Change from all-time low	3.89%
Change from open	-0.14%
Day's gap	0.14%
Dollar volume	CNY 54M
High price	CNY 7.30
Low price	CNY 7.19
Monthly RSI	34.97
Open price	CNY 7.22
Position in 52-week range	18.18%
Previous close	CNY 7.21
Price vs 150-day SMA	-20.09%
Price vs 20-day SMA	-9.01%
Price vs 200-day SMA	-24.27%
Price vs 50-day SMA	-13.45%
Relative volume	0.65
RSI	27.8
Sharpe ratio	-1.17
Sharpe ratio (3Y)	-0.01
Sortino ratio	-1.47
Sortino ratio (3Y)	0.14
Volume	7.5M
Weekly RSI	28.76
YTD price change	-28.9%
YTD total return	-27.61%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	527.2M
Shares change (QoQ)	-16.06%
Shares change (YoY)	-0.64%
Shares held by insiders	0.19%
Shares held by institutions	2.07%
Shares outstanding	2.2B

Deeper analysis on SHE/301301

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SHE/301301 report

Is a complete SHE/301301 research report available?

No complete published report is available for she/301301 (SHE/301301) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SHE/301301 (SHE/301301)

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/301301

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/301301 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SHE/301301

Frequently asked questions